Powered by

BrainStorm to Host Tomorrow a Conference Call to Announce Its "Right To Try" Policy

Jun 25, 2018 - PR Newswire

 BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will hold a conference call tomorrow, June 26th at 08:30am Eastern Time, to announce its policy in regards to the "Right To Try" legislation.

About BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone...